Chronic liver disease after acute non-A, non-B viral hepatitis - PubMed (original) (raw)

• PMID: 115740

Chronic liver disease after acute non-A, non-B viral hepatitis

J Rakela et al. Gastroenterology. 1979 Dec.

Abstract

We have analyzed the frequency of chronicity and its distribution according to epidemiologic background following acute non-A, non-B hepatitis. Eighteen of 45 cases (40%) developed chronic liver disease. The incidence of chronicity was significantly higher following transfusion and among drug addicts (54% and 58%) than among patients without obvious source of infection (20%). Chronic active hepatitis developed in 4 of 13 patients (31%) with posttransfusion hepatitis. This lesion was not observed among the addicts or the patients without obvious source for the acute hepatitis.

PubMed Disclaimer

Similar articles

• Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
  Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Koretz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L. Seeff LB, et al. Hepatology. 2001 Feb;33(2):455-63. doi: 10.1053/jhep.2001.21905. Hepatology. 2001. PMID: 11172349
• Chronic liver disease after acute non-A non-B viral hepatitis.
  Sampliner RE. Sampliner RE. Gastroenterology. 1980 May;78(5 Pt 1):1113. Gastroenterology. 1980. PMID: 6769743 No abstract available.
• [Rapid development of liver cirrhosis following acute non-A, non-B hepatitis].
  Huth M, Liehr H, Spech HJ. Huth M, et al. Z Gastroenterol. 1989 May;27(5):272-8. Z Gastroenterol. 1989. PMID: 2502883 German.
• [Development of chronic non-A, non-B hepatitis and transition to liver cirrhosis].
  Kiyosawa K, Akahane Y, Yamamura N, Koike Y, Sodeyama T, Furuta S. Kiyosawa K, et al. Nihon Rinsho. 1981 Oct;39(10):3242-50. Nihon Rinsho. 1981. PMID: 6803022 Review. Japanese. No abstract available.
• [Non-A, non-B fulminant hepatitis].
  Koji T, Munehisa T, Kusumoto Y, Ishii N, Furukawa R. Koji T, et al. Nihon Rinsho. 1981 Oct;39(10):3257-62. Nihon Rinsho. 1981. PMID: 6803024 Review. Japanese. No abstract available.

Cited by

• Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.
  Conlon PJ, Walshe JJ, Smyth EG, McNamara EB, Donohoe J, Carmody M. Conlon PJ, et al. Ir J Med Sci. 1993 Apr;162(4):145-7. doi: 10.1007/BF02942105. Ir J Med Sci. 1993. PMID: 7685747
• The course of chronic active hepatitis.
  Arthurs Y, Doyle GD, Fielding JF. Arthurs Y, et al. Ir J Med Sci. 1982 Oct;151(10):298-303. doi: 10.1007/BF02940208. Ir J Med Sci. 1982. PMID: 7174240 No abstract available.
• Morphometric investigations on the portal tracts of the liver, the differentiation of variable progression in chronic persistent hepatitis.
  Volmer J, Lüders CJ. Volmer J, et al. Virchows Arch A Pathol Anat Histol. 1981;392(3):321-37. doi: 10.1007/BF02155669. Virchows Arch A Pathol Anat Histol. 1981. PMID: 7269230
• Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
  Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al. Saito I, et al. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6547-9. doi: 10.1073/pnas.87.17.6547. Proc Natl Acad Sci U S A. 1990. PMID: 2168552 Free PMC article.
• Chronic hepatitis: a review.
  Bradbear RA. Bradbear RA. J R Soc Med. 1985 May;78(5):391-6. doi: 10.1177/014107688507800509. J R Soc Med. 1985. PMID: 3921709 Free PMC article. Review. No abstract available.

MeSH terms